Learning Objectives. STI Update. Case 1 6/1/2016
|
|
- Barbra Weaver
- 6 years ago
- Views:
Transcription
1 Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe the current epidemiology of syphilis, testing algorithm and management considerations. Discuss the current recommendations regarding gonorrhea treatment Case 1 32 year old bisexual asymptomatic male presents for routine physical exam. He is usually the insertive partner and also engages in oral sex. STI screening should include a)rpr, urine GC NAAT, rectal GC NAAT, pharyngeal Gonorrhea NAAT, HIV antigen antibody testing b)rpr, urine/urethral GC NAAT, HIV antigen antibody testing c)syphilis EIA, urine GC NAAT, throat culture, HIV antibody d)rpr or Syphilis EIA, urine GC NAAT, Pharyngeal Gonorrhea NAAT, HIV antigen antibody testing 1
2 Screening for STI Screening for Chlamydia All adults and adolescents from ages 13 to 64 should be tested at least once for HIV. Annual chlamydia screening of all sexually active women younger than 25 years, as well as older women with risk factors such as new or multiple sex partners, or a sex partner who has a sexually transmitted infection Annual gonorrhea screening for all sexually active women younger than 25 years, as well as older women with risk factors such as new or multiple sex partners, or a sex partner who has a sexually transmitted infection. Syphilis, HIV, chlamydia, and hepatitis B screening for all pregnant women, and gonorrhea screening for at-risk pregnant women starting early in pregnancy, with repeat testing as needed. Screening at least once a year for syphilis, chlamydia, and gonorrhea for all sexually active MSM or bisexual. MSM with multiple or anonymous partners should be screened more frequently for STDs (i.e., at 3-to-6 month intervals). Anyone who has unsafe sex or shares injection drug equipment should get tested for HIV at least once a year. Sexually active gay and bisexual men may benefit from more frequent testing (e.g., every 3 to 6 months). Screening for Gonorrhea Screening for Trichomonas 2
3 Screening for Syphilis Screening for herpes Pregnant Women: All pregnant women at the first prenatal visit. Retest early in the third trimester and at delivery if at high risk. Men Who have Sex With Men (MSM): At least annually for sexually active MSM. Every 3 to 6 months if at increased risk. Persons with HIV: For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology. Screening for Hepatitis B and C Screening in correctional facilities 3
4 Screening for STI in HIV infected All women should be screened for trichomoniasis, and all women aged <25 years should be screened for Chlamydia trachomatis infection Men and women should be screened for gonorrhea and chlamydia infection at initial presentation and then annually thereafter if at risk for infection Retesting in 3months is indicated in men and women found to be positive for gonorrhea and chlamydial infections and women found to be positive for trichomoniasis on initial screening, because of high reinfection rates DHHS HIV for Primary Care Extra genital testing Obtaining an accurate sexual history can be challenging in any population, and provider comfort is essential to ensure an accurate assessment. It is possible that patients may not be completely forthcoming about exposure at some of these sites, and that infections may be missed if the patient is screened based on their history (versus screened at all sites regardless of history). However, at this time it is recommended that clinicians use the patient history to guide site specific screening. CDC Q & A STI presenting as genital, anal or perianal ulcer Specific evaluation includes 1) syphilis serology, darkfield examination, or PCR testing if available; 2) culture or PCR testing for genital herpes; and 3) serologic testing for typespecific HSV antibody. In settings where chancroid is prevalent, a test for Haemophilus ducreyi also should be performed Two FDA cleared PCR tests are available for the diagnosis of HSV 1 and HSV 2 in genital specimens. Type specific serology for HSV 2 might be helpful in identifying persons with genital herpes. In addition, biopsy of ulcers can help identify the cause of ulcers that are unusual or that do not respond to initial therapy. BD Probe Tec MultiCode RTx IsoAmp HSV Assay FDA approved HSV PCR Age M/F ORAL/GENITAL TYPE 1 &2 DIFFERENTIATION >17yrs M&F External Anogenital Yes Clinician collected Symptomatic >18yrs F Vaginal Yes Symptomatic Vaginal only All M&F Genital & Oral No 4
5 Treatment of Ulcerative STI Because early treatment decreases the possibility of transmission, public health standards require health care providers to presumptively treat any patient with a suspected case of infectious syphilis at the initial visit, even before test results are available. Presumptive treatment of a patient with a suspected first episode of genital herpes also is recommended, because successful treatment depends on prompt initiation of therapy. 25% with genital ulcer have no diagnosis after complete laboratory evaluation HSV serology Type specific Glycoprotein G based assays Might be useful in the following scenarios: 1)Recurrent genital symptoms or atypical symptoms with negative HSV PCR or culture 2)Clinical diagnosis of genital herpes without laboratory confirmation 3)Partner has genital herpes Chancroid Incidence of chancroid has declined steadily from 1987, when over 5000 cases were reported to the CDC. In 2010, 24 cases were reported from 9 different states. 5 were from Texas. Chancroid Definite Isolation of H. ducreyi from the lesion Probable Clinical findings compatible with the diagnosis plus negative darkfield microscopic examination for Treponema pallidum, negative serologic test for syphilis, and negative culture for HSV or a clinical presentation not typical for herpes NY State H. ducreyi PCR 5
6 Chancroid Treatment Repeat HIV and Syphilis serology 3months after treatment. Granuloma inguinale (Donovanosis) Klebsiella granulomatis (Calymmatobacterium granulomatis) Rare in USA. Endemic in India, Papua, New Guinea, Caribbean, Central Australia and Southern Africa. Painless, slowly progressive, ulcerative, vascular, beefy without regional lymphadenopathy, subcutaneous granulomas (pseudobuboes) Donovan bodies on crush stain or biopsy Azithromycin 1gm weekly or 500mg daily for 3 weeks or till lesions resolved Lymphogranuloma Venereum Chlamydia serovars L1, L2, L3 Self limited genital ulcer or papule followed by unilateral tender inguinal or femoral lymphadenopathy Women or MSM Proctocolitis. Untreated colorectal fistula, reactive arthropathy. NAAT for CT. PCR genotyping distinguish LGV CT from non LGV CT Chlamydia serology might be supportive. CFT>1:64 or MIFT >1:256 Doxycycline 100mg twice a dayx21 days. Azithromycin 1gm weekly x3 weeks. Aspiration of buboes or I & D as needed. 6
7 Syphilis Treatment 7
8 Ocular Syphilis Cases of ocular syphilis should be reported to your state or local health department within 24 hours of diagnosis. Ocular syphilis cases diagnosed since December 1, 2014, should be reported to your local or state health department. The case definition for an ocular syphilis case is as follows: a person with clinical symptoms or signs consistent with ocular disease (i.e. uveitis, panuveitis, diminished visual acuity, blindness, optic neuropathy, interstitial keratitis, anterior uveitis, and retinal vasculitis) with syphilis of any stage. Pre antibiotic clinical samples (whole blood, primary lesions and moist secondary lesions, CSF or ocular fluid) should be saved and stored at 80 C immediately upon collection for molecular typing. If you are a healthcare provider and need advice from CDC regarding the clinical management of ocular syphilis, contact Dr. Kimberly Workowski at or kgw2@cdc.gov. If you are planning on collecting clinical specimens for molecular typing and need assistance with the collection procedure or shipment of samples, please contact Dr. Allan Pillay at or ajp7@cdc.gov. Ocular syphilis ongoing questions Lack of clarity whether this represents: Outbreak of a more neuro/ocular tropic syphilis strain versus Increased awareness of a known complication of syphilis in the setting of rising number of syphilis cases Limitations of current surveillance system to detect/record ocular syphilis cases 8
9 Syphilis follow up Clinical and serologic evaluation should be performed at 6 and 12 months after treatment Definite criteria for cure or failure have not been well established Decline in titer is variable RPR titers might decline more slowly for persons previously treated for syphilis. person s stage of syphilis (earlier stages are more likely to decline fourfold and become negative) Initial nontreponemal antibody titers (lower titers are less likely to decline fourfold than higher titers) Optimal management of persons who have less than a fourfold decline in titers after treatment of syphilis is unclear. If CSF pleocytosis was present, CSF every 6month until cell count is normal. Treatment Failure Signs or symptoms that persist or recur and those with at least a fourfold increase in nontreponemal test titer persisting for >2 weeks likely experienced treatment failure or were re infected Because treatment failure usually cannot be reliably distinguished from reinfection with T. pallidum, a CSF analysis also should be performed; treatment should be guided by CSF findings Failure of nontreponemal test titers to decline fourfold within 6 12 months after therapy for primary or secondary syphilis. 15% 20% of persons with primary and secondary syphilis treated with the recommended therapy will not achieve the fourfold decline in nontreponemal titer used to define response at 1 year after treatment For retreatment, weekly injections of benzathine penicillin G 2.4 million units IM for 3 weeks is recommended, unless CSF examination indicates that neurosyphilis is present. Case 2 Our patient s RPR is reactive at 1:8 dilution and TP PA confirms syphilis diagnosis. RPR was non reactive 11months ago. Physical exam was negative for ulcer, gumma or rash. For contact tracing, testing and treatment, which of his sex partners should be notified? a) None. He has latent syphilis b) Partners in last 30 days c) Partners in last 90 days d) Partners in past year. 9
10 Management of Sex Partners Gonorrhea by Age, Sex and Sexual behavior Sexual contact with a person who receives a diagnosis of primary, secondary, or early latent syphilis within 90 days preceding the diagnosis should be treated presumptively for early syphilis, even if serologic test results are negative. Persons who have had sexual contact with a person who receives a diagnosis of primary, secondary, or early latent syphilis >90 days before the diagnosis should be treated presumptively for early syphilis if serologic test results are not immediately available and the opportunity for follow-up is uncertain. If serologic tests are negative, no treatment is needed. If serologic tests are positive, treatment should be based on clinical and serologic evaluation and stage of syphilis Long-term sex partners of persons who have late latent syphilis should be evaluated clinically and serologically for syphilis and treated on the basis of the evaluation s findings. The following sex partners of persons with syphilis are considered at risk for infection and should be confidentially notified of the exposure and need for evaluation: partners who have had sexual contact within 1) 3 months plus the duration of symptoms for persons who receive a diagnosis of primary syphilis, 2) 6 months plus duration of symptoms for those with secondary syphilis, and 3) 1 year for persons with early latent syphilis. Chlamydia March 2014 MMWR Updated Recommendations for laboratory based Detection of Chlamydia trachomatis and Neisseria gonorrhea NAAT Recommended for genital and extra genital testing by CDC. Extra genital not FDA cleared and needs individual lab verification Preferred specimens Male: First catch urine Female Vaginal(equivalent to cervical, superior to urine) Exceptions: Child sexual assault involving boys, rectal and oropharyngeal infections in prepubescent girls, Potential gonorrhea treatment failure 10
11 Antimicrobials used for Gonorrhea Evolution of Gonorrhea treatment The epidemiology of antimicrobial resistance guides decisions about gonococcal treatment recommendations. In 2007, emergence of fluoroquinolone resistant N. gonorrhoeae in the United States prompted CDC to cease recommending fluoroquinolones for treatment of gonorrhea, leaving cephalosporins as the only remaining class of antimicrobials available for treatment of gonorrhea in the United States Reflecting concern about emerging gonococcal resistance, CDC s 2010 STD treatment guidelines recommended dual therapy for gonorrhea with a cephalosporin plus either azithromycin or doxycycline, even if NAAT for C. trachomatis was negative at the time of treatment , the MIC for Cefixime in the United States and many other countries increased, suggesting that the effectiveness of cefixime might be waning. Treatment failures with cefixime or other oral cephalosporins have been reported in Asia, Europe,South Africa, and Canada. Ceftriaxone treatment failures for pharyngeal infections have been reported in Australia, Japan, and Europe. As a result, CDC no longer recommends the routine use of cefixime as a first line regimen for treatment of gonorrhea in the United States. In addition, U.S. gonococcal strains with elevated MICs to cefixime also are likely to be resistant to tetracyclines but susceptible to azithromycin. Gonococcal isolates with elevated Ceftriaxone MIC 2015 Recommended Rx for Uncomplicated GC infections of Cervix, urethra, rectum and Pharynx Ceftriaxone 250mg IM x1 dose plus Azithromycin 1gm PO x1 dose Doxycycline 100mg PO BID X7days acceptable for azithro allergic 11
12 Cephalosporin allergy alternatives Gemifloxacin 320mg po plus Azithromycin 2gms Gentamicin IM 240mg (6ml in 2 divided doses) plus Azithromycin 2gms Contraindicated in pregnancy If used for pharyngeal infection, test of cure in 14days either with NAAT or culture. Other Practical Considerations Timing: Often in clinical practice, patients are treated with azithromycin for urethritis on one day, and screening tests return positive for gonorrhea on the next. The goal of dual therapy is to have both drugs active simultaneously. Because azithromycin s half life is 68 hours, it is probably safe to administer ceftriaxone within five days of the azithromycin dose. However, the converse is not true. Ceftriaxone s half life is much shorter ( hours), thus, if a patient is given ceftriaxone in a clinic, and fails to pick up azithromycin at the pharmacy for a couple of days, the patient should receive a second dose of ceftriaxone when they take the azithromycin. Other practical considerations EPT Expedited Partner Therapy Delivery of antibiotic therapy by index patienteither by prescription or actual medication Not recommended for MSM due to high risk of coinfection NYS EPT for CT only: 1gm Azithromycin single oral dose GC and CT Sex partner management Sex partners should be evaluated, tested and treated if they had sexual contact with the patient during the 60days preceding the onset of symptoms or diagnosis of GC or Chlamydia The most recent sex partner should be evaluated and treated even if the time of the last sexual contact was >60days before symptom onset or diagnosis. 12
13 Chlamydia Azithromycin favored over doxycycline due to adherence issue Concern azithromycin less effective especially for rectal Chlamydia Some use doxycycline preferentially for second episode/treatment failure for rectal Chlamydia Mycoplasma genitalium Emerging STI Cause of male urethritis 15 20% of NGU 20 25% of non Chlamydial NGU 30% of persistent or recurrent urethritis Unknown if can cause male infertility or male anogenital tract disease syndromes Pathogenic role in women also less clear? enhanced HIV risk Mycoplasma genitalium Very slow growing organism. Difficult to recover in culture NAAT preferred method. Not commercially available 7 day doxycycline ineffective(median cure rate 31%) 1gm single dose azithromycin more effective Failure associated with macrolide resistance Moxifloxacin 400mg x7, 10 or 14days for treatment failures. Post Test Case 1 32 year old bisexual asymptomatic male presents for routine physical exam. He is usually the insertive partner and also engages in oral sex. STI screening should include a) RPR, urine GC NAAT, rectal GC NAAT, pharyngeal Gonorrhea NAAT, HIV antigen antibody testing b) RPR, urine/urethral GC NAAT, HIV antigen antibody testing c) Syphilis EIA, urine GC NAAT, throat culture, HIV antibody d) RPR or Syphilis EIA, urine GC NAAT, Pharyngeal Gonorrhea NAAT, HIV antigen antibody testing 13
14 Questions? 14
STDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationSyphilis Treatment Protocol
STD, HIV, AND TB SECTION Syphilis Treatment Protocol CLINICAL GUIDANCE FOR PRIMARY AND SECONDARY SYPHILIS AND LATENT SYPHILIS www.lekarzol.com (4/2016) Page 1 of 8 Table of Contents Description... 3 Stages
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More informationManagement of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationSexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationDrugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal
Drugs for UTIs and STDs Dr.Vishaal Bhat Associate Professor MMMC Manipal Classification of UTI s Clinical: Asymptomatic (98%) Symptomatic (1-2%) Anatomical: Lower tract dis: asymptomatic bacteriuria and
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011
Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before
George Walton, MPH, CPH, MLS(ASCP) CM STD Program Manager Bureau of HIV, STD, and Hepatitis September 15, 2015 1 1) Discuss the changing epidemiology of syphilis in Iowa; 2) Explore key populations affected
More information9/29/2014. Genital Ulcer Diseases GENITAL HSV. HSV-2: Primer. Genital Ulcer Diseases Does It Hurt? Painful. Painless. Chancroid Genital herpes simplex
Genital Ulcer Diseases Mychelle Y. Farmer, MD, FAAP STD/HIV Prevention Training Center at Johns Hopkins Genital Ulcer Diseases Does It Hurt? Painful Chancroid Genital herpes simplex Painless Syphilis Lymphogranuloma
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationGUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
WHO/HIV_AIDS/2001.01 WHO/RHR/01.10 Original: English Distr.: General GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization Copyright World Health Organization 2001.
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationChancroid Table of Contents
Subsection: Chancroid Page 1 of 8 Chancroid Table of Contents Chancroid Fact Sheet Subsection: Chancroid Page 2 of 8 Chancroid (Haemophilus ducreyi) Overview (1,2) For a more complete description of chancroid,
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationLymphogranuloma Venereum (LGV) Surveillance Project
Lymphogranuloma Venereum (LGV) Surveillance Project Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a type of Chlamydia trachomatis (serovars L1, L2, L3) that
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationManagement of Syphilis in Patients with HIV
Management of Syphilis in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More informationSyphilis in the 21 st Century: Sex, Sores, Science, and Surveillance. Syphilis in Men
Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance Syphilis in Men Kenneth A. Katz, MD, MSc, MSCE Kaiser Permanente, San Francisco, CA AAD Annual Meeting Washington, D.C. March 2, 2019
More informationSexually Transmitted Diseases
Table of content Sexually Transmitted Diseases Judith A. Lightfoot DO, FACOI Update on the prevalence of STD s in the US Which populations are greatly affected? Should we be alarmed? How does this affect
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationGuidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing
Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Recommendations from the an expert consultation meeting held at CDC January 13-15,
More informationSexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationClinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD
Clinical Education Initiative Support@ceitraining.org ADOLESCENTS AND STDS: CASE STUDIES Tara Babu, MD 2/16/2017 Adolescents and STDs: Case Studies [video transcript] 00:00:08 - Hello, my name is Tia Babu
More informationSexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
More informationHPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010
HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 21 Health Protection Surveillance Centre, www.hpsc.ie Version 1. May 212 Table of Contents Acknowledgements... 5 Key Points... 5 Introduction... 7 Methods...
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationOverview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?
Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public
More informationSyphilis Update: New Presentations of an Old Disease
Syphilis Update: New Presentations of an Old Disease Bradley Stoner, MD, PhD Washington University in St. Louis Disclosure: Bradley Stoner, MD, PhD STDs in the United States Where do we stand right now?
More information4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annualmore than 1.5 million
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationMSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs
Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient
More informationUse of Treponemal Immunoassays for Screening and Diagnosis of Syphilis
Use of Treponemal Immunoassays for Screening and Diagnosis of Syphilis Guidance for Medical Providers and Laboratories in California These guidelines were developed by the California Department of Public
More informationPractice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -
ASK SCREEN Test for HIV and STI Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically - Routinely obtain a thorough sexual history from all
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationSTI in British Columbia: Annual Surveillance Report
STI in British Columbia: Annual Surveillance Report 212 Contact Information BC Centre for Disease Control Clinical Prevention Services 655 West 12th Avenue Vancouver BC V5Z 4R4 Phone: 64-77-5621 Fax: 66-77-564
More informationThe Great Imitator Revealed: Syphilis
The Great Imitator Revealed: Syphilis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles David Geffen School of Medicine Los Angeles, California Learning
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL
PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE
More informationCase 1. Case 1. Physical exam
11/13/2012 Case 28 year-old woman Complains of very painful lesions in vulvar area Increasing severity since 4 days Pain aggravated by urination She has a slight fever and also complains of headache and
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationProfessor Jonathan Ross
SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL
DISCLOSURE PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Dr. Feller does not have any actual or potential conflicts of interest to disclose and will not be discussing
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016
Sexually Transmitted Infection surveillance in Northern Ireland 2017 An analysis of data for the calendar year 2016 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationInternationell utblick STI/HIV i världen
Internationell utblick STI/HIV i världen Magnus Unemo, PhD, Assoc. Professor, Director Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology Örebro University
More informationNotifiable Sexually Transmitted Infections 2009 Annual Report
Notifiable Sexually Transmitted Infections 29 Annual Report 21 Government of Alberta Alberta Health and Wellness, Surveillance and Assessment Send inquiries to: Health.Surveillance@gov.ab.ca Notifiable
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More informationReplaces: 04/13/17. / Formulated: 7/05 SYPHLIS
Effective Date: 81017 Replaces: 041317 Page 1 of 7 POLICY: The Texas Department of Criminal Justice (TDCJ) will identify, test, and manage all offenders with suspected or confirmed syphilis with a uniform
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More informationClinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP
Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationOverview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017
Sexually Transmitted Diseases: Key Clinical Information for 2017 Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public Health
More informationSexually Transmitted Infections
Sexually Transmitted Infections Christine Hogan M.D. Sexually Transmitted Pathogens Bacteria Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Ureaplasma urealyticum Treponema pallidum
More informationDISCLOSURES 9/25/2018. Sexually Transmitted Infections: New and Not so New Bugs. Center for Community Practice. Designated by AIDS Institute
Sexually Transmitted Infections: New and Not so New Bugs Melinda S Godfrey MBA, MS, NP University of Rochester Infectious Disease Division Monroe County STD Clinic New York State, STD Center of Excellence
More informationGenital Ulcer Disease
Genital Ulcer Disease Cornelis Kees Rietmeijer, MD, PhD Colorado School of Public Health University of Colorado Denver Disclaimer All slides in this slide set can be used for educational purposes with
More informationMYCOPLASMA GENITALIUM A PRACTICAL GUIDE
MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE
More informationScreening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016
Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More information2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE
2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Clinical Professor of Pediatrics, SUNY at Buffalo School
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationDISCLOSURES LEARNING OBJECTIVES 10/17/2018. NPA Conference Saratoga Srings NY, October Sexually Transmitted Infections: New and Not so New Bugs
Sexually Transmitted Infections: New and Not so New Bugs Melinda S Godfrey MBA, MS, NP University of Rochester Infectious Disease Division Monroe County STD Clinic New York State, STD Center of Excellence
More informationSay Ahhh!, STDs in Maine. Emer Smith, Maine CDC,
Say Ahhh!, STDs in Maine Emer Smith, Maine CDC, emer.smith@maine.gov Say AHHH! : STDs in Maine Emer S. Smith, MPH Maine Center for Disease Control & Prevention HIV, STD, & Viral Hepatitis Program April
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationPublic/Private Partnerships: Intervening in the Spread of Syphilis
Public/Private Partnerships: Intervening in the Spread of Diana Torres-Burgos MD, MPH Gerard Castaneda, BSN Alana Thomas, BS STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline overview Stages
More informationGAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016
GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know
More informationSTIs. Sexually Transmitted Infections. Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia
Sexually Transmitted Infections Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia FORMATTED: 11/17/15 Learning Objectives After attending this presentation,
More informationDisclosure Information Julie Stoltey, MD MPH
Courtesy CDC Public Health Image Library The New Yorker 2012 2016 Update on Testing, Treatment, and Gonorrhea Resistance Julie Stoltey, MD, MPH STD Control Branch-California Dept. of Public Health Assistant
More informationDr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014
THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining
More informationSEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5) BACTERIAL VAGINOSIS 1 clindamycin cream 2 Cleocin Vaginal Cream 2% vaginal cream Adults: 1 applicatorful at bedtime for 7 days metronidazole
More information